| Reduced lung-cancer mortality with low-dose computed tomographic screening National Lung Screening Trial Research Team New England Journal of Medicine 365 (5), 395-409, 2011 | 12352* | 2011 |
| Results of initial low-dose computed tomographic screening for lung cancer National Lung Screening Trial Research Team New England Journal of Medicine 368 (21), 1980-1991, 2013 | 1180 | 2013 |
| Results of the two incidence screenings in the National Lung Screening Trial DR Aberle, S DeMello, CD Berg, WC Black, B Brewer, TR Church, ... New England Journal of Medicine 369 (10), 920-931, 2013 | 611 | 2013 |
| Association of coronary artery calcification and mortality in the national lung screening trial: a comparison of three scoring methods C Chiles, F Duan, GW Gladish, JG Ravenel, SG Baginski, BS Snyder, ... Radiology 276 (1), 82-90, 2015 | 337 | 2015 |
| Prediction of Survival by [18F]Fluorodeoxyglucose Positron Emission Tomography in Patients With Locally Advanced Non–Small-Cell Lung Cancer Undergoing … M Machtay, F Duan, BA Siegel, BS Snyder, JJ Gorelick, JS Reddin, ... Journal of clinical oncology 31 (30), 3823-3830, 2013 | 226 | 2013 |
| Impact of lung cancer screening results on participant health‐related quality of life and state anxiety in the National Lung Screening Trial IF Gareen, F Duan, EM Greco, BS Snyder, PM Boiselle, ER Park, ... Cancer 120 (21), 3401-3409, 2014 | 181 | 2014 |
| The Impact of Positron Emission Tomography with 18F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial GL Andriole, L Kostakoglu, A Chau, F Duan, U Mahmood, DA Mankoff, ... The Journal of urology 201 (2), 322-331, 2019 | 156 | 2019 |
| Airflow limitation and histology shift in the National Lung Screening Trial. The NLST-ACRIN cohort substudy RP Young, F Duan, C Chiles, RJ Hopkins, GD Gamble, EM Greco, ... American journal of respiratory and critical care medicine 192 (9), 1060-1067, 2015 | 145 | 2015 |
| African‐American/White differences in breast carcinoma: p53 alterations and other tumor characteristics BA Jones, SV Kasl, CL Howe, M Lachman, R Dubrow, MMC Curnen, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2004 | 136 | 2004 |
| Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination DS Gierada, P Pinsky, H Nath, C Chiles, F Duan, DR Aberle Journal of the National Cancer Institute 106 (11), dju284, 2014 | 129 | 2014 |
| 18F-fluoride PET used for treatment monitoring of systemic cancer therapy: results from the National Oncologic PET Registry BE Hillner, BA Siegel, L Hanna, F Duan, B Quinn, AF Shields Journal of Nuclear Medicine 56 (2), 222-228, 2015 | 107 | 2015 |
| Impact of 18F-fluoride PET in patients with known prostate cancer: initial results from the National Oncologic PET Registry BE Hillner, BA Siegel, L Hanna, F Duan, AF Shields, RE Coleman Journal of Nuclear Medicine 55 (4), 574-581, 2014 | 105 | 2014 |
| Genomic and clinical analyses of 2p24 and 12q13‐q14 amplification in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group FG Barr, F Duan, LM Smith, D Gustafson, M Pitts, S Hammond, ... Genes, chromosomes and cancer 48 (8), 661-672, 2009 | 105 | 2009 |
| Multicenter Trial of [18F]fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging of Head and Neck Cancer and Negative Predictive … VJ Lowe, F Duan, RM Subramaniam, JRD Sicks, J Romanoff, T Bartel, ... Journal of Clinical Oncology 37 (20), 1704-1712, 2019 | 102 | 2019 |
| The microenvironment in hepatocyte regeneration and function in rats with advanced cirrhosis L Liu, GR Yannam, T Nishikawa, T Yamamoto, H Basma, R Ito, M Nagaya, ... Hepatology 55 (5), 1529-1539, 2012 | 98 | 2012 |
| Pretreatment 18F-FDG PET textural features in locally advanced non–small cell lung cancer: secondary analysis of ACRIN 6668/RTOG 0235 N Ohri, F Duan, BS Snyder, B Wei, M Machtay, A Alavi, BA Siegel, ... Journal of Nuclear Medicine 57 (6), 842-848, 2016 | 96 | 2016 |
| A phase II study of 3′-deoxy-3′-18F-fluorothymidine PET in the assessment of early response of breast cancer to neoadjuvant chemotherapy: results from ACRIN 6688 L Kostakoglu, F Duan, MO Idowu, PR Jolles, HD Bear, M Muzi, J Cormack, ... Journal of Nuclear Medicine 56 (11), 1681-1689, 2015 | 85 | 2015 |
| Pretreatment FDG-PET metrics in stage III non–small cell lung cancer: ACRIN 6668/RTOG 0235 N Ohri, F Duan, M Machtay, JJ Gorelick, BS Snyder, A Alavi, BA Siegel, ... Journal of the National Cancer Institute 107 (4), djv004, 2015 | 82 | 2015 |
| Genomic and clinical analysis of amplification of the 13q31 chromosomal region in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group JL Reichek, F Duan, LM Smith, DM Gustafson, RS O'Connor, C Zhang, ... Clinical Cancer Research 17 (6), 1463-1473, 2011 | 81 | 2011 |
| Optimal FDG PET/CT volumetric parameters for risk stratification in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 trial A Salavati, F Duan, BS Snyder, B Wei, S Houshmand, B Khiewvan, ... European journal of nuclear medicine and molecular imaging 44, 1969-1983, 2017 | 79 | 2017 |
